PortfoliosLab logoPortfoliosLab logo
COO vs. LMAT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

COO vs. LMAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

COO vs. LMAT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
COO
The Cooper Companies, Inc.
-12.76%-10.85%-2.83%14.47%-21.06%15.33%13.10%26.27%16.84%24.59%
LMAT
LeMaitre Vascular, Inc.
34.92%-10.95%63.63%24.60%-7.40%25.10%14.09%53.77%-25.13%26.58%

Fundamentals

Market Cap

COO:

$14.06B

LMAT:

$2.51B

EPS

COO:

$2.02

LMAT:

$2.47

PE Ratio

COO:

35.45

LMAT:

44.28

PS Ratio

COO:

3.43

LMAT:

10.24

PB Ratio

COO:

1.68

LMAT:

6.37

Total Revenue (TTM)

COO:

$4.15B

LMAT:

$249.60M

Gross Profit (TTM)

COO:

$2.67B

LMAT:

$178.54M

EBITDA (TTM)

COO:

$962.00M

LMAT:

$85.42M

Returns By Period

In the year-to-date period, COO achieves a -12.76% return, which is significantly lower than LMAT's 34.92% return. Over the past 10 years, COO has underperformed LMAT with an annualized return of 6.16%, while LMAT has yielded a comparatively higher 22.62% annualized return.


COO

1D
3.16%
1M
-14.55%
YTD
-12.76%
6M
4.29%
1Y
-15.23%
3Y*
-8.50%
5Y*
-5.79%
10Y*
6.16%

LMAT

1D
2.15%
1M
1.15%
YTD
34.92%
6M
25.33%
1Y
31.31%
3Y*
29.74%
5Y*
18.74%
10Y*
22.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

COO vs. LMAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COO
COO Risk / Return Rank: 2121
Overall Rank
COO Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
COO Sortino Ratio Rank: 2222
Sortino Ratio Rank
COO Omega Ratio Rank: 2222
Omega Ratio Rank
COO Calmar Ratio Rank: 2121
Calmar Ratio Rank
COO Martin Ratio Rank: 2020
Martin Ratio Rank

LMAT
LMAT Risk / Return Rank: 7070
Overall Rank
LMAT Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
LMAT Sortino Ratio Rank: 7070
Sortino Ratio Rank
LMAT Omega Ratio Rank: 6969
Omega Ratio Rank
LMAT Calmar Ratio Rank: 7474
Calmar Ratio Rank
LMAT Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COO vs. LMAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


COOLMATDifference

Sharpe ratio

Return per unit of total volatility

-0.44

0.80

-1.24

Sortino ratio

Return per unit of downside risk

-0.38

1.55

-1.94

Omega ratio

Gain probability vs. loss probability

0.95

1.21

-0.26

Calmar ratio

Return relative to maximum drawdown

-0.61

1.66

-2.27

Martin ratio

Return relative to average drawdown

-1.16

3.00

-4.15

COO vs. LMAT - Sharpe Ratio Comparison

The current COO Sharpe Ratio is -0.44, which is lower than the LMAT Sharpe Ratio of 0.80. The chart below compares the historical Sharpe Ratios of COO and LMAT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


COOLMATDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.44

0.80

-1.24

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.20

0.52

-0.72

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.55

-0.32

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

0.36

-0.24

Correlation

The correlation between COO and LMAT is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

COO vs. LMAT - Dividend Comparison

COO has not paid dividends to shareholders, while LMAT's dividend yield for the trailing twelve months is around 0.78%.


TTM20252024202320222021202020192018201720162015
COO
The Cooper Companies, Inc.
0.00%0.00%0.00%0.02%0.02%0.01%0.02%0.02%0.02%0.03%0.03%0.04%
LMAT
LeMaitre Vascular, Inc.
0.78%1.23%0.69%0.99%1.09%0.88%0.94%0.95%1.18%0.69%0.71%0.93%

Drawdowns

COO vs. LMAT - Drawdown Comparison

The maximum COO drawdown since its inception was -98.88%, which is greater than LMAT's maximum drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for COO and LMAT.


Loading graphics...

Drawdown Indicators


COOLMATDifference

Max Drawdown

Largest peak-to-trough decline

-98.88%

-75.69%

-23.19%

Max Drawdown (1Y)

Largest decline over 1 year

-23.83%

-19.91%

-3.92%

Max Drawdown (5Y)

Largest decline over 5 years

-45.45%

-37.93%

-7.52%

Max Drawdown (10Y)

Largest decline over 10 years

-45.45%

-47.65%

+2.20%

Current Drawdown

Current decline from peak

-37.25%

-3.75%

-33.50%

Average Drawdown

Average peak-to-trough decline

-40.55%

-19.04%

-21.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.66%

11.01%

+1.65%

Volatility

COO vs. LMAT - Volatility Comparison

The Cooper Companies, Inc. (COO) has a higher volatility of 8.16% compared to LeMaitre Vascular, Inc. (LMAT) at 7.72%. This indicates that COO's price experiences larger fluctuations and is considered to be riskier than LMAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


COOLMATDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.16%

7.72%

+0.44%

Volatility (6M)

Calculated over the trailing 6-month period

18.98%

27.47%

-8.49%

Volatility (1Y)

Calculated over the trailing 1-year period

35.02%

39.28%

-4.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.68%

36.27%

-7.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.61%

41.51%

-13.90%

Financials

COO vs. LMAT - Financials Comparison

This section allows you to compare key financial metrics between The Cooper Companies, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
1.02B
64.45M
(COO) Total Revenue
(LMAT) Total Revenue
Values in USD except per share items

COO vs. LMAT - Profitability Comparison

The chart below illustrates the profitability comparison between The Cooper Companies, Inc. and LeMaitre Vascular, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%20222023202420252026
67.9%
71.7%
Portfolio components
COO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, The Cooper Companies, Inc. reported a gross profit of 695.20M and revenue of 1.02B. Therefore, the gross margin over that period was 67.9%.

LMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, LeMaitre Vascular, Inc. reported a gross profit of 46.19M and revenue of 64.45M. Therefore, the gross margin over that period was 71.7%.

COO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, The Cooper Companies, Inc. reported an operating income of 212.80M and revenue of 1.02B, resulting in an operating margin of 20.8%.

LMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, LeMaitre Vascular, Inc. reported an operating income of 18.83M and revenue of 64.45M, resulting in an operating margin of 29.2%.

COO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, The Cooper Companies, Inc. reported a net income of 130.80M and revenue of 1.02B, resulting in a net margin of 12.8%.

LMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, LeMaitre Vascular, Inc. reported a net income of 15.58M and revenue of 64.45M, resulting in a net margin of 24.2%.